Galderma Laboratories, L.P. v. Sun Pharmaceutical Industries Limited
1:16-cv-01003
Overview
Parties
Defendant
Sun Pharmaceutical Industries Limited NPE (University / Research)
Represented By
9 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Sun Pharmaceutical Industries Inc. Operating Company
Represented By
6 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Plaintiff
TCD Royalty Sub LLC Operating Company
Represented By
6 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Galderma Laboratories, L.P. NPE (Individual / Inventor)
Represented By
9 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Counter Defendant
Nestle Skin Health S.A. Operating Company
Represented By
6 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 13 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Dr. Reddy’s Laboratories, Ltd. et al. v. GALDERMA LABORATORIES, INC. et al.
Dr. Reddy’s Laboratories, Ltd. et al. v. GALDERMA LABORATORIES, INC. et al.
Dr. Reddy’s Laboratories, Ltd. et al. v. GALDERMA LABORATORIES, INC. et al.
Amneal Pharmaceuticals, LLC et al. v. Supernus Pharmaceuticals, Inc. et al.
Patents Involved
There are 10 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7211267
Methods of treating acne
|
Filed: 2002-04-05
Issued: 2007-05-01
|
Expired (Term Ended)
Expires: 2022-04-05
|
|
|
US7749532
Once daily formulations of tetracyclines
|
Filed: 2004-04-07
Issued: 2010-07-06
|
Active (1.1 yrs remaining)
+1351d PTA
Expires: 2027-12-19
|
|
|
US8206740
Once daily formulations of tetracyclines
|
Filed: 2008-06-06
Issued: 2012-06-26
|
Expired (Term Ended)
Expires: 2025-12-24
|
|
|
US8394405
Once daily formulations of tetracyclines
|
Filed: 2010-12-17
Issued: 2013-03-12
|
Active (4.1 yrs remaining)
Expires: 2030-12-17
|
|
|
US8394406
Once daily formulations of tetracyclines
|
Filed: 2010-12-17
Issued: 2013-03-12
|
Active (4.1 yrs remaining)
Expires: 2030-12-17
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
62
Dispositive
0
Granted
1
Denied
0
Pending / Review
49
Motions by Category
Key Dispositive Motions & Rulings